Inicio › Cáncer de próstata › Maryland
Ensayos clínicos de Cáncer de próstata en Maryland
69 estudios sobre Cáncer de próstata buscan participantes en Maryland.
Ciudades en Maryland
Texto oficial del estudio (inglés)
Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance
- National Institutes of Health Clinical Center, Bethesda
ReclutandoFase 2
Edades de 18 a 120 · Hombres · Actualizado el 13 nov 2026 · NCT07574541Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- Suburban Hospital, Bethesda
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 13 nov 2026 · NCT04423211Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer
- National Institutes of Health Clinical Center, Bethesda
ReclutandoFase 1/2
Edades de 18 a 120 · Todos los sexos · Actualizado el 13 nov 2026 · NCT07667400Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 12 nov 2026 · NCT05691465Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- National Institutes of Health Clinical Center, Bethesda
- FMH James M Stockman Cancer Institute, Frederick
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT03866382Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL
- National Institutes of Health Clinical Center, Bethesda
ReclutandoEstudio observacional
Edades de 18 en adelante · Hombres · Actualizado el 12 nov 2026 · NCT05588128Sacral Neuromodulation for Male Overactive Bladder (MOAB)
- Anne Arundel Urology, Annapolis
Reclutando
Edades de 18 en adelante · Hombres · Actualizado el 12 nov 2026 · NCT06511141Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy
- National Institutes of Health Clinical Center, Bethesda
ReclutandoEstudio observacional
Edades de 18 a 120 · Hombres · Actualizado el 12 nov 2026 · NCT01834001Collection of Blood From Patients With Prostate Cancer
- National Institutes of Health Clinical Center, Bethesda
ReclutandoEstudio observacional
Edades de 18 en adelante · Hombres · Actualizado el 12 nov 2026 · NCT00923221Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue
- National Institutes of Health Clinical Center, Bethesda
ReclutandoEstudio observacional
Edades de 18 en adelante · Hombres · Actualizado el 12 nov 2026 · NCT02594202Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer
- National Institutes of Health Clinical Center, Bethesda
ReclutandoFase 2
Edades de 18 a 120 · Hombres · Actualizado el 10 nov 2026 · NCT06161506Collection of Blood From Patients With Cancer
- National Institutes of Health Clinical Center, Bethesda
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT00034216Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
- National Institutes of Health Clinical Center, Bethesda
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT00451022The Vanguard Study: Testing a New Way to Screen for Cancer
- Walter Reed National Military Medical Center, Bethesda
ReclutandoSe aceptan voluntarios sanos
Edades de 45 a 75 · Todos los sexos · Actualizado el 6 nov 2026 · NCT06995898WATER IV PCa (AS Sub-study)
- Johns Hopkins University, Baltimore
Reclutando
Edades de 45 en adelante · Hombres · Actualizado el 6 nov 2026 · NCT07650448Robot-Assisted Prostate Biopsy With a Novel Ultrasound Probe
- Johns Hopkins Hospital, Baltimore
ReclutandoFase 1
Edades de 40 a 75 · Hombres · Actualizado el 6 nov 2026 · NCT07271017Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
- University of Maryland Greenebaum Cancer Center, Baltimore
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 5 nov 2026 · NCT07745361Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mercy Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- y 10 más
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 40 a 75 · Todos los sexos · Actualizado el 4 nov 2026 · NCT05334069Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
- Maryland Proton Treatment Center, Baltimore
- University of Maryland/Greenebaum Cancer Center, Baltimore
- UM Upper Chesapeake Medical Center, Bel Air
- y 3 más
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 3 nov 2026 · NCT07200830The COSMYC Trial (COmbined Suppression of MYC)
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 30 oct 2026 · NCT06922318A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- Greenebaum Comprehensive Cancer Center ( Site 0021), Baltimore
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 30 oct 2026 · NCT06925737Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
ReclutandoFase 1
Edades de 18 a 100 · Hombres · Actualizado el 29 oct 2026 · NCT05519449Exercise in Prostate Cancer
- Johns Hopkins University, Baltimore
Reclutando
Edades de 18 en adelante · Hombres · Actualizado el 29 oct 2026 · NCT06165302A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer
- National Institutes of Health Clinical Center, Bethesda
ReclutandoFase 1/2
Edades de 18 a 110 · Hombres · Actualizado el 29 oct 2026 · NCT04633252Precision-Based Genomics in Prostate Cancer
- National Institutes of Health Clinical Center, Bethesda
ReclutandoEstudio observacional
Edades de 18 a 120 · Hombres · Actualizado el 26 oct 2026 · NCT04706663A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Johns Hopkins University, Baltimore
- Maryland Oncology Hematology, PA, Rockville
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 26 oct 2026 · NCT06172478Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Maryland Proton Treatment Center, Baltimore
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Veterans Administration Medical Center-Baltimore, Baltimore
- y 7 más
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 23 oct 2026 · NCT05946213Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer
- Johns Hopkins University, Baltimore
ReclutandoEstudio observacional
Edades de 18 en adelante · Hombres · Actualizado el 22 oct 2026 · NCT04489719A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Baltimore Veterans Affairs Medical Center ( Site 0069), Baltimore
- Greenebaum Comprehensive Cancer Center ( Site 0049), Baltimore
- Chesapeake Urology ( Site 0009), Towson
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 20 oct 2026 · NCT06136650A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- University of Maryland Greenebaum Cancer Center, Baltimore
- Johns Hopkins Hospital Sidney Kimmell Comprehensive Cancer Center, Baltimore
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 20 oct 2026 · NCT07213674A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy
- National Institutes of Health Clinical Center, Bethesda
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 20 oct 2026 · NCT05361798Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
- National Institutes of Health Clinical Center, Bethesda
ReclutandoEstudio observacional
Edades de 3 en adelante · Todos los sexos · Actualizado el 16 oct 2026 · NCT01441089Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy
- National Institutes of Health Clinical Center, Bethesda
ReclutandoFase 2
Edades de 18 a 120 · Hombres · Actualizado el 16 oct 2026 · NCT06096870Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor
- National Institutes of Health Clinical Center, Bethesda
ReclutandoFase 2
Edades de 18 a 120 · Hombres · Actualizado el 16 oct 2026 · NCT05616650Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer
- National Institutes of Health Clinical Center, Bethesda
Reclutando
Edades de 18 en adelante · Hombres · Actualizado el 16 oct 2026 · NCT04692675Men at High Genetic Risk for Prostate Cancer
- National Institutes of Health Clinical Center, Bethesda
ReclutandoEstudio observacional
Edades de 30 a 75 · Hombres · Actualizado el 16 oct 2026 · NCT03805919Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer
- National Institutes of Health Clinical Center, Bethesda
ReclutandoEstudio observacional
Edades de 18 en adelante · Hombres · Actualizado el 16 oct 2026 · NCT03354416Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
- Research Site, Baltimore
- Research Site, Baltimore
- Research Site, Towson
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 15 oct 2026 · NCT07711002Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- Johns Hopkins Hospital, Baltimore
ReclutandoFase 3
Edades de 18 a 100 · Hombres · Actualizado el 15 oct 2026 · NCT06855277A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Research Site, Towson
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 14 oct 2026 · NCT06952803De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.